The approved vaccine (Arexvy) is a GSK vaccine. It's also not an mRNA vaccine - it's recombinant subunit vaccine (ie, you tinker with microbes to spew out relev

The approved vaccine (Arexvy) is a GSK vaccine. It's also not an mRNA vaccine - it's recombinant subunit vaccine (ie, you tinker with microbes to spew out relevant pieces of the virus which you harvest and purify). Edit: Also your linked commentary basically completely hinges on what we believe the risk of RSV to actually be (fair). The lower bound estimate provided by tallying up actual death certificates is just that - a lower bound. The linked study for that number dedicates a huge pile of its discussion section to the very weakness of just using death certificates. I'm not saying that the 14k number must be true, but it's also quite unlikely that the 35 per year number is the right order of magnitude as well.